Diseases of the Nervous System | Hypertension, Phase II
Regulating Blood Pressure During Recovery from Intracerebral Hemorrhage and Ischemic Stroke (REDUCE)
Volunteers
Health Professionals
What is the purpose of this trial?
This study is looking to compare the effect of spironolactone-containing antihypertensive medications versus standard antihypertensive medications on home blood pressure in intracerebral hemorrhage (ICH) survivors.
- Trial withAmerican Heart Association
- Ages18 years and older
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Adam de Havenon, MD, MSCI
- Adam Jasne, MD
- Ahmed Elmashad
- Amit Mehta
- Barbara Gordon-Kundu, MD
- Caitlin Loomis, MD
- Guido J. Falcone, MD, ScD, MPH
- Jaehan Park
- James A. Giles, MD, PhD, MPHS, MRCP
- Jorge Rodriguez
- Joseph Schindler, MD
- Kevin Sheth, MD
- Lauren Hachmann Sansing, MD, MS, FAHA, FANA
- Mark Warman, MD, MSc, MA
- Melissa Mariscal, MD
- N. Abimbola Sunmonu, MD/PhD
- Nils Petersen, MD/PhD, MSc
- Nishant K. Mishra, MD, PhD, FRCP, FAHA
- Rachel Forman, MD
- Reshma Narula, MD
- Richa Sharma, MD, MPH
- Ruth Arnold
- Srikant Rangaraju, MBBS, MS
- Stefanie Cappucci
- Syed Ali
- Last Updated04/14/2024
- Study HIC#2000029811